Kimberly R Jordan

22PUBLICATIONS
150CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsInnate immunityGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 19, 2026
Inhibiting CXCR2 remodels the tumor microenvironment and blunts tumor progression and dissemination of high-grade serous carcinoma.

|May 18, 2026
Cross-assay RNA modeling reveals cancer biomarkers.

|Dec 04, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Aug 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.

Lily L Nguyen, Zachary L Watson, Raquel Ortega

|Aug 08, 2024
The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.

Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post

Pageof 4

Frequent Collaborators

10 joint publications

Benjamin G Bitler

6 joint publications

Elizabeth R Woodruff

5 joint publications

Tomomi M Yamamoto

4 joint publications

Kian Behbakht